Pharmacological and clinical evaluation of cariprazine-dopamine D2/3 and 5-HT1A receptor partial agonist in the treatment of schizophrenia and major depressive disorder
XU Lei
LI Jing-hua
FENG Yu-fei
Keywords：cariprazineschizophreniabipolar Ⅰ disorderdopamine D3 and D2 receptors partial agonist5-HT1A receptors partial agonistpharmacologyclinical evaluation
Publication Date：2017-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)